Obesity as a risk factor for Clostridium difficile infection

Clinical Infectious Diseases

Volumn 57, Issue 4, 2013, Pages 489-493

  Bishara, Jihad ^a,b   Farah, Raymond ^c,d   Mograbi, Julnar ^e,f   Khalaila, Wissam ^e,f   Abu Elheja, Omar ^e,f   Mahamid, Mahmud ^e,f   Nseir, William ^d,e,f  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Rebecca Sieff Government Hospital   (Israel)

^d BAR ILAN UNIVERSITY   (Israel)

^e Department of Internal Medicine ^*  (Israel)

^f Israel   (Israel)

Author keywords

Bacteroidetes; BMI; Clostridium difficile; Firmicutes; Microbiota

Indexed keywords

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

BACTEROIDETES; BMI; CLOSTRIDIUM DIFFICILE; FIRMICUTES; MICROBIOTA;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 84880949013     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit280     Document Type: Article

References (31)

1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994; 330:257-62.
2. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235:363-72.
3. Barbut F, Petit JC. Epidemiology of Clostridium difficile-associated diarrhea. Clin Microbiol Infect 2001; 7:405-41.
4. Thorpe CM, Gorbach SL. Update on Clostridium difficile. Curr Treat Options Gastroenterol 2006; 9:265-71.
5. Ondrdonk AB, Garrett WS. Gas gangrene and other Clostridiumassociated diseases. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Churchill Livingstone, Elsevier: 2010:3103-9.
6. Al-Tureihi FI, Hassoun A, Wolf-Klein G, Isenberg H. Albumin, length of stay, and proton pump inhibitors: key factors in Clostridium difficileassociated diarrhea in nursing home patients. J Am Med Dir Assoc 2005; 6:105-8.
7. Spenser RC. Clinical impact and associated costs of Clostridium difficile-associated diarrhea. J Antimicrob Chemother 1998; 41(suppl): C5-12.
8. Kyne I, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-53.
9. Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J. Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea. Infect Control Hosp Epidemiol 2007; 28:377-81.
10. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhea: a systemic review. J Antimicrob Chemother 2003; 511:339-50.
11. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acidsuppressive agents and the risk of community-acquired Clostridium difficile-associated diarrhea. JAMA 2005; 21:2989-95.
12. Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, Allison MC. Proton pump inhibitors therapy is a risk factor for Clostridium difficile-associated diarrhea. Aliment Pharmacol Ther 2006; 24:613-9.
13. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas SJ. Bacteriotherapy using fecal flora: toying with human motions. Clin Gastroenterol 2004; 38:475-83.
14. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis 2001; 1:101-14.
15. Manges AR, Labbe A, Loo VG, et al. Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. J Infect Dis 2010; 202:1877-84.
16. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial population in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002; 51:448-54.
17. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444:1027-31.
18. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
19. World Health Organization. WHO obesity: preventing and managing the global epidemic. Report of the WHO consultation. World Health Organ Tech Rep Ser 2000; 894:1-253.
20. Kaye KS, Marchaim D, Chen TY, et al. Predictors of nosocomial bloodstream infections in older adults. J Am Geriatr Soc 2011; 59:622-7.
21. Bercault N, Boulain T, Kuteifan K, Wolf M, Runge I, Fleury JC. Obesity-related excess mortality rate in an adult intensive care unit: a risk-adjusted matched cohort study. Crit Care Med 2004; 32:998-1003.
22. Dossett LA, Dageforde LA, Swenson BR, et al. Obesity and site-specific nosocomial infection risk in the intensive care unit. Surg Infect 2009; 10:137-42.
23. Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011; 12:653-9.
24. Huttunen R, Syrjänen J. Obesity and the outcome of infection. Lancet Infect Dis 2010; 10:442-43.
25. Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 2009; 10:280-9.
26. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Nature 2006; 444:1022-3.
27. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One 2009; 4:e7125.
28. Santacruz A, Collado MC, Garcia-Valdes L, et al. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 2010; 104: 83-92.
29. Balamurugan R, George G, Kabeerdoss J, Hepsiba J, Chandragunasekaran AM, Ramakrishna BS. Quantitative differences in intestinal Faecalibacterium prausnitzii in obese Indian children. Br J Nutr 2010; 103:335-8.
30. Formiguera X, Canton A. Obesity: epidemiology and clinical aspects. Best Pract Res Clin Gastroenterol 2004; 18:1125-46.
31. Berghofer A, Pischon T, Reinhold T, Apovian CM, Sharma AM, Willich SN. Obesity prevalence from a European perspective: a systematic review. BMC Public Health 2008; 8:200.